118 related articles for article (PubMed ID: 3079086)
21. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
[No Abstract] [Full Text] [Related]
22. Cardiac transplantation in the sixth decade of life.
Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
[No Abstract] [Full Text] [Related]
23. Low-dose cyclosporine or azathioprine one year after renal transplantation.
Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
[No Abstract] [Full Text] [Related]
24. Prophylactic ATG or OKT3 in liver transplantation in the presence of contraindications to cyclosporine (CyA) or azathioprine (AZA).
Gugenheim J; Samuel D; Chaland P; Saliba F; Bismuth H
Transplant Proc; 1989 Feb; 21(1 Pt 2):2257. PubMed ID: 2652733
[No Abstract] [Full Text] [Related]
25. Use of OKT3 for late acute rejection in liver transplantation.
Samuel D; Gugenheim J; Canon C; Saliba F; Bismuth H
Transplant Proc; 1990 Aug; 22(4):1767-8. PubMed ID: 2117804
[No Abstract] [Full Text] [Related]
26. Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator.
Perkins JD; Wiesner RH; Banks PM; LaRusso NF; Krom RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2474-5. PubMed ID: 2856283
[No Abstract] [Full Text] [Related]
27. Early experience with anti-Tac in clinical renal transplantation.
Kirkman RL; Shapiro ME; Carpenter CB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
Transplant Proc; 1989 Feb; 21(1 Pt 2):1766-8. PubMed ID: 2652578
[No Abstract] [Full Text] [Related]
28. Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
Klar E; Theilmann L; Hoffmann V; Hofmann W; Kraus T; Mehrabi A; Herfarth C
Transplant Proc; 1998 Nov; 30(7):3567-9. PubMed ID: 9838562
[No Abstract] [Full Text] [Related]
29. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
[No Abstract] [Full Text] [Related]
30. Analysis of cytomegalovirus reactivation after liver transplantation in cytomegalovirus immunoglobulin G antibody seropositive patients prior to transplantation.
Cuervas-Mons V; Garrido A; Barrios C; Portero F; de la Loma A; Albillos A; Ardaiz J; Turrión VS; Mora NP; Herrera J
Transplant Proc; 1990 Aug; 22(4):1798-9. PubMed ID: 2167530
[No Abstract] [Full Text] [Related]
31. Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation.
Gozzo ML; Avolio AW; Colacicco L; Agnes S; Forni F; Barbaresi G; Castagneto M
Transplant Proc; 1993 Apr; 25(2):1760-1. PubMed ID: 8097065
[No Abstract] [Full Text] [Related]
32. [Influence on the rejection of the canine liver allograft through pregnancy (author's transl)].
Lie TS; Böhmer F; Nakano H; Ebata H; Möritz B
Z Immunitatsforsch Exp Klin Immunol; 1974 Apr; 146(5):460-6. PubMed ID: 4282994
[No Abstract] [Full Text] [Related]
33. Induction therapy with OKT3 in pediatric liver-transplant recipients.
Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
[TBL] [Abstract][Full Text] [Related]
34. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
[No Abstract] [Full Text] [Related]
35. Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression.
Merion RM; White DJ; Calne RY
Transplant Proc; 1983 Dec; 15(4):2172-7. PubMed ID: 6369690
[No Abstract] [Full Text] [Related]
36. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Kremer AB; Barnes L; Hirsch RL; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
[No Abstract] [Full Text] [Related]
37. Signs of early rejection of liver transplant in dogs.
Olszewski W; Polański J; Sawicki Z; Machowski Z; Rosnowska M
Pol Med J; 1972; 11(6):1590-5. PubMed ID: 4572846
[No Abstract] [Full Text] [Related]
38. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
[No Abstract] [Full Text] [Related]
39. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
St Cyr JA; Elick B; Freese D; Sharp H; Payne W; Bloomer J; Stock P; Snover D; Najarian JS; Ascher NL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2451-3. PubMed ID: 3274535
[No Abstract] [Full Text] [Related]
40. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
